Europe Laxative Market, By Type (Osmotic laxatives, Stimulant laxatives, Bulk laxatives, Lubricant and Emollient laxatives), Flavors (With Flavor, Without Flavor), Source (Natural, Synthetic, Others), Indication (Chronic Constipation, irritable bowel Syndrome with Constipation, Opioid-Induced constipation, Acute constipation, Others), Mode of Purchase (Prescription, Over-the-Counter), Dosage Form (Tablets, Capsules, Powder, Liquid and Gels, Suppositories, Others), Route of Administration (Oral, Rectal), Population Type (Children, Adults), Sales Channel (Hospitals, Elderly Care Centers, Home Healthcare, Pharmacy Stores, Grocer/Health and Beauty Stores, Others), Distribution Channel (Direct Sales, Wholesalers, Others) – Industry Trends and Forecast to 2031.
Europe Laxative Market Analysis and Size
The key factors driving the laxative market are the rising incidence of digestive disorders, including constipation, irritable bowel syndrome (IBS), and chronic constipation, rising Changing Dietary Habits, and increasing awareness. Europe has an aging population, and older individuals are more prone to constipation and related digestive issues. This demographic shift has fueled the demand for laxatives, as seniors seek relief from constipation symptoms. This has driven the demand for laxatives. Digestive issues can be caused by various factors, including dietary choices and sedentary lifestyles. Therefore, the increased prevalence of constipation and acclimatization of a sedentary lifestyle are the major drivers that propelled the demand of the market in the forecast period.
Data Bridge Market Research analyses that the Europe Laxative market which was USD 1,621.87 million in 2023, is likely to reach USD 2,522.41 million by 2031, and is expected to undergo a CAGR of 5.81% during the forecast period. “Hospital” dominates the sales channel segment of the market due to the growing demand for products that provide medical, nursing, and other health-related OTC services to patients. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Report Scope and Market Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2024 to 2031
|
|
Base Year
|
2023
|
|
Historic Years
|
2022 (Customizable to 2016-2021)
|
|
Quantitative Units
|
Revenue in USD Million, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
By Type (Osmotic laxatives, Stimulant laxatives, Bulk laxatives, Lubricant and Emollient laxatives), Flavors (With Flavor, Without Flavor), Source (Natural, Synthetic, Others), Indication (Chronic Constipation, irritable bowel Syndrome with Constipation, Opioid-Induced constipation, Acute constipation, Others), Mode of Purchase (Prescription, Over-the-Counter), Dosage Form (Tablets, Capsules, Powder, Liquid and Gels, Suppositories, Others), Route of Administration (Oral, Rectal), Population Type (Children, Adults), Sales Channel (Hospitals, Elderly Care Centers, Home Healthcare, Pharmacy Stores, Grocer/Health and Beauty Stores, Others), Distribution Channel (Direct Sales, Wholesalers, Others)
|
|
Countries Covered
|
Germany, France, U.K., Italy, Spain, Russia, Netherlands, Switzerland, Belgium, Turkey, Rest of Europe
|
|
Market Players Covered
|
F. Hoffmann-La Roche Ltd. (Switzerland), Mylan N.V. (U.S.), Teva Pharmaceutical Industries Ltd. (Ireland), Sanofi (France), Pfizer Inc. (U.S.), GSK plc (U.K.), Novartis AG (Switzerland), Merck & Co., Inc. (U.S.), AstraZeneca (U.K.), Johnson & Johnson Services, Inc. (U.S.), Hikma Pharmaceuticals PLC (U.K.), Dr. Reddy's Laboratories Ltd. (India), Lupin (India), Fresenius Kabi AG (Germany), Aurobindo Pharma (India), Cipla Inc. (U.S.), Bausch Health Companies Inc. (Canada), Amneal Pharmaceuticals LLC. (U.S.), Apotex Inc. (Canada), Eli Lilly and Company (U.S.)
|
|
Market Opportunities
|
|
Market Definition
Laxatives are a type of medicated drugs, which relieve acute, and constipation and irritable bowel syndrome, by loosening the faeces and bowel movement. The laxatives are also implemented prior to before bowel procedures. The laxatives are available as over the counter (OTC), which means the laxative scan be purchased without a prescription of the doctor.
Europe Laxative Market Dynamics
Drivers
- Rising geriatric population
The geriatric population has a significant impact on the laxative market due to the increased prevalence of constipation and gastrointestinal issues in this age group. Constipation is more common among the elderly, with various factors, such as reduced mobility, medication use, and age-related changes in bowel function, contributing to this issue. As a result, the geriatric population has a higher demand for laxative products, which can drive the market.
- Increasing healthcare infrastructure
An enhanced healthcare infrastructure often leads to better diagnostic capabilities and increased awareness of gastrointestinal conditions, including constipation. This can result in more individuals seeking medical attention for these issues, potentially increasing the demand for laxatives.
Moreover, the growing healthcare infrastructure may incorporate telemedicine and telehealth solutions, making it easier for individuals to access medical advice and treatment recommendations for digestive health concerns. This can lead to more informed use of laxatives leading to boost the market.
Opportunities
- Increasing Research and Development Activities
The introduction of new laxative products can diversify the product portfolio available in the market. This can provide consumers with a wider range of options, including products that may better suit their preferences and needs. Increased R&D activities can lead to the development of innovative laxative products. Researchers may explore novel formulations, delivery methods, and mechanisms of action to create more effective and tolerable laxatives. This, in turn, will extend profitable opportunities for the market.
Restraints/Challenges
- Rising prevalence of eating disorders
Individuals with eating disorders, especially bulimia nervosa, may misuse or abuse laxatives as a means of purging after binge-eating episodes. This misuse is not a legitimate medical indication but rather a harmful behavior associated with the disorders. The misuse of laxatives among individuals with eating disorders can lead to a range of health risks, including electrolyte imbalances, dehydration, and gastrointestinal damage. The severity of these risks depends on the extent of laxative abuse. This can be a challenge for the market.
- High cost
Developing new drugs, whether they are laxatives or other pharmaceuticals, is expensive due to the need for extensive research, clinical trials, and regulatory compliance. These high development costs can lead to a need for higher prices to recoup investments which is expected to hamper the growth of the laxative market.
-
Lack of skilled professionals
The shortage of skilled professionals may lead to delays in the diagnosis and treatment of gastrointestinal disorders that require laxatives. Patients might experience symptoms for longer periods before receiving appropriate medical attention. Skilled professionals are responsible for developing comprehensive treatment plans for patients with gastrointestinal issues which may act as challenge for the growth of the laxative market.
This laxative market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the laxative market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Recent Development
- In March 2021, Purdue Pharma L.P. announced the launch of two Senokot Dietary Supplement Products namely Senokot Laxative Gummies – Blueberry Pomegranate flavor and Senokot Laxative Tea. Senokot Dietary Supplement Laxative Gummies - Blueberry Pomegranate Flavor is a new flavor of Senokot Laxative Gummies for gentle overnight constipation treatment. These products will be further expands the product portfolio of the company
Europe Laxative Market Scope
The laxative market is segmented on the type, flavours, source, indication, mode of purchase, dosage form, route of administration, population type, sales channel and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Type
- Osmotic Laxatives
- Osmotic Laxatives With Electrolytes
- Golytely
- Colyte
- Others
- Osmotic Laxatives Without Electrolytes
- Magnesium Hydroxide Solution
- Epsom Salts
- Lactulose
- Others
- Osmotic Laxatives With Electrolytes
- Stimulant Laxatives
- Bisacodyl
- Castor Oil
- Senna
- Phenolphthalein
- Others
- Bulk Laxatives
- Psyllium
- Methyl Cellulose
- Polycarbophil
- Others
- Lubricant and Emollient Laxatives
- Mineral Oil
- Glycerin Suppositories
- Others
Flavors
- With Flavor
- Fruit
- Herbal
- Others
- Without Flavor
Source
- Natural
- Psyllium
- Rhubarb
- Senna and Slippery Elm
- Synthetic
- Phenolphthalein
- Bisacodyl
- Picosulfate
- Oxyphenisatin
- Others
Indication
- Chronic Constipation
- Irritable Bowel Syndrome with Constipation
- Opioid-Induced Constipation
- Acute Constipation
- Others.
Mode of Purchase
- Prescription
- Over-the-Counter
Dosage Form
- Tablets
- Capsules
- Powder
- Liquid
- Gels
- Suppositories
- Others
Route of Administration
- Oral
- Rectal
Population Type
- Children
- Adults
Sales Channel
- Hospitals
- Elderly Care Centers
- Home Healthcare
- Pharmacy Stores
- Grocer/Health and Beauty Stores
- Others
Distribution Channel
- Direct Sales
- Wholesalers
- Others
Europe Laxative Market Regional Analysis/Insights
The laxative market is analyzed and market size insights and trends are provided by country, type, flavours, source, indication, mode of purchase, dosage form, route of administration, population type, sales channel and distribution channel as referenced above.
The countries covered in the market report are Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey and rest of Europe.
Germany is expected to dominate as well as expected to grow with the highest market share in the market due to increased demand of OTC products as well as wide access to products as per patients need in the country.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure growth Installed base and New Technology Penetration
The laxative market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for laxative market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the Europe Laxative market. The data is available for historic period 2010-2020.
Competitive Landscape and Europe Laxative market Share Analysis
The laxative market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to laxative market.
Some of the major players operating in the laxative Market are:
- F. Hoffmann-La Roche Ltd. (Switzerland)
- Mylan N.V. (U.S.)
- Teva Pharmaceutical Industries Ltd. (Ireland)
- Sanofi (France)
- Pfizer Inc. (U.S.)
- GSK plc (U.K.)
- Novartis AG (Switzerland)
- Merck & Co., Inc. (U.S.)
- AstraZeneca (U.K.)
- Johnson & Johnson Services, Inc. (U.S.)
- Hikma Pharmaceuticals PLC (U.K.)
- Dr. Reddy's Laboratories Ltd. (India)
- Lupin (India)
- Fresenius Kabi AG (Germany)
- Aurobindo Pharma (India)
- Cipla Inc. (U.S.)
- Bausch Health Companies Inc. (Canada)
- Amneal Pharmaceuticals LLC. (U.S.)
- Apotex Inc. (Canada)
- Eli Lilly and Company (U.S.)
SKU-